
Khatol S. Shahnan Shah
Examiner (ID: 17930, Phone: (571)272-0863 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645 |
| Total Applications | 691 |
| Issued Applications | 342 |
| Pending Applications | 101 |
| Abandoned Applications | 266 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7719863
[patent_doc_number] => 20120009198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-12
[patent_title] => 'Compositions and Methods for Modulating Immune Response'
[patent_app_type] => utility
[patent_app_number] => 12/831565
[patent_app_country] => US
[patent_app_date] => 2010-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5755
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20120009198.pdf
[firstpage_image] =>[orig_patent_app_number] => 12831565
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/831565 | Compositions and Methods for Modulating Immune Response | Jul 6, 2010 | Abandoned |
Array
(
[id] => 5952253
[patent_doc_number] => 20110033402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'Solubilized benzoyl small molecule'
[patent_app_type] => utility
[patent_app_number] => 12/803544
[patent_app_country] => US
[patent_app_date] => 2010-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7517
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20110033402.pdf
[firstpage_image] =>[orig_patent_app_number] => 12803544
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/803544 | Solubilized benzoyl small molecule | Jun 28, 2010 | Issued |
Array
(
[id] => 10586672
[patent_doc_number] => 09308268
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-12
[patent_title] => 'Solubilized benzoyl peroxyde acne'
[patent_app_type] => utility
[patent_app_number] => 12/803543
[patent_app_country] => US
[patent_app_date] => 2010-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 8368
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12803543
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/803543 | Solubilized benzoyl peroxyde acne | Jun 28, 2010 | Issued |
Array
(
[id] => 13179849
[patent_doc_number] => 10105412
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-23
[patent_title] => Vaccines and compositions against
[patent_app_type] => utility
[patent_app_number] => 12/826084
[patent_app_country] => US
[patent_app_date] => 2010-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 20530
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12826084
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/826084 | Vaccines and compositions against | Jun 28, 2010 | Issued |
Array
(
[id] => 6602218
[patent_doc_number] => 20100322977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-23
[patent_title] => 'BIOMATERIALS, COMPOSITIONS, AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 12/795485
[patent_app_country] => US
[patent_app_date] => 2010-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 15120
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0322/20100322977.pdf
[firstpage_image] =>[orig_patent_app_number] => 12795485
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/795485 | BIOMATERIALS, COMPOSITIONS, AND METHODS | Jun 6, 2010 | Abandoned |
Array
(
[id] => 6148790
[patent_doc_number] => 20110020385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'COMBINATIONS OF PNEUMOCOCCAL RrgB CLADES'
[patent_app_type] => utility
[patent_app_number] => 12/791186
[patent_app_country] => US
[patent_app_date] => 2010-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 35629
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20110020385.pdf
[firstpage_image] =>[orig_patent_app_number] => 12791186
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/791186 | Combinations of pneumococcal RrgB clades | May 31, 2010 | Issued |
Array
(
[id] => 6391370
[patent_doc_number] => 20100303756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-02
[patent_title] => 'Methods of Treating Urogenital-Neurological Disorders Using Interleukin Retargeted Endopepidases'
[patent_app_type] => utility
[patent_app_number] => 12/781106
[patent_app_country] => US
[patent_app_date] => 2010-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 56770
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0303/20100303756.pdf
[firstpage_image] =>[orig_patent_app_number] => 12781106
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/781106 | Methods of Treating Urogenital-Neurological Disorders Using Interleukin Retargeted Endopepidases | May 16, 2010 | Abandoned |
Array
(
[id] => 8220802
[patent_doc_number] => 20120135007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-31
[patent_title] => 'Anti-LPS Enriched Immunoglobulin Preparations For The Treatment And/Or Prophylaxis Of A Pathologic Disorder'
[patent_app_type] => utility
[patent_app_number] => 13/265252
[patent_app_country] => US
[patent_app_date] => 2010-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 31627
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13265252
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/265252 | Anti-LPS enriched immunoglobulin preparations for the treatment and/or prophylaxis of a pathologic disorder | Apr 26, 2010 | Issued |
Array
(
[id] => 8621354
[patent_doc_number] => 08354267
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-15
[patent_title] => 'Microbial fuel cell'
[patent_app_type] => utility
[patent_app_number] => 12/660200
[patent_app_country] => US
[patent_app_date] => 2010-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11614
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12660200
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/660200 | Microbial fuel cell | Feb 22, 2010 | Issued |
Array
(
[id] => 6245479
[patent_doc_number] => 20100135969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'METHOD OF TREATING CANCER USING PLATELET RELEASATE'
[patent_app_type] => utility
[patent_app_number] => 12/700087
[patent_app_country] => US
[patent_app_date] => 2010-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9999
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20100135969.pdf
[firstpage_image] =>[orig_patent_app_number] => 12700087
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/700087 | METHOD OF TREATING CANCER USING PLATELET RELEASATE | Feb 3, 2010 | Abandoned |
Array
(
[id] => 9581726
[patent_doc_number] => 08771727
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-08
[patent_title] => 'Microfluidized oil-in-water emulsions and vaccine compositions'
[patent_app_type] => utility
[patent_app_number] => 12/650715
[patent_app_country] => US
[patent_app_date] => 2009-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15438
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12650715
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/650715 | Microfluidized oil-in-water emulsions and vaccine compositions | Dec 30, 2009 | Issued |
Array
(
[id] => 6582218
[patent_doc_number] => 20100291133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'RECOMBINANT PROTEIN CONTAINING A C-TERMINAL FRAGMENT OF PLASMODIUM MSP-1'
[patent_app_type] => utility
[patent_app_number] => 12/647674
[patent_app_country] => US
[patent_app_date] => 2009-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 12315
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20100291133.pdf
[firstpage_image] =>[orig_patent_app_number] => 12647674
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/647674 | RECOMBINANT PROTEIN CONTAINING A C-TERMINAL FRAGMENT OF PLASMODIUM MSP-1 | Dec 27, 2009 | Abandoned |
Array
(
[id] => 7573117
[patent_doc_number] => 20110268773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-03
[patent_title] => 'INCLUSION BODIES, BACTERIAL CELLS AND COMPOSITIONS CONTAINING THEM AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/142295
[patent_app_country] => US
[patent_app_date] => 2009-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 6184
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0268/20110268773.pdf
[firstpage_image] =>[orig_patent_app_number] => 13142295
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/142295 | INCLUSION BODIES, BACTERIAL CELLS AND COMPOSITIONS CONTAINING THEM AND USES THEREOF | Dec 21, 2009 | Abandoned |
Array
(
[id] => 6290089
[patent_doc_number] => 20100158953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-24
[patent_title] => 'METHOD FOR CONTROLLING STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A POLYSACCHARIDE MOLECULAR WEIGHT'
[patent_app_type] => utility
[patent_app_number] => 12/640769
[patent_app_country] => US
[patent_app_date] => 2009-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5597
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20100158953.pdf
[firstpage_image] =>[orig_patent_app_number] => 12640769
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/640769 | Method for controlling Streptococcus pneumoniae serotype 19A polysaccharide molecular weight | Dec 16, 2009 | Issued |
Array
(
[id] => 6486127
[patent_doc_number] => 20100093035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'NOVEL STREPTOCOCCUS ANTIGENS'
[patent_app_type] => utility
[patent_app_number] => 12/634464
[patent_app_country] => US
[patent_app_date] => 2009-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 15997
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12634464
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/634464 | Streptococcus antigens | Dec 8, 2009 | Issued |
Array
(
[id] => 7510085
[patent_doc_number] => 20110256179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'PHARMACEUTICAL PREPARATION COMPRISING A COMBINATION OF STREPTOCOCCUS STRAINS AND LACTOBACILLUS STRAINS'
[patent_app_type] => utility
[patent_app_number] => 12/998615
[patent_app_country] => US
[patent_app_date] => 2009-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6796
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20110256179.pdf
[firstpage_image] =>[orig_patent_app_number] => 12998615
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/998615 | PHARMACEUTICAL PREPARATION COMPRISING A COMBINATION OF STREPTOCOCCUS STRAINS AND LACTOBACILLUS STRAINS | Nov 16, 2009 | Abandoned |
Array
(
[id] => 6618503
[patent_doc_number] => 20100099844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'Hydrophobin Solution Containing Antifoam'
[patent_app_type] => utility
[patent_app_number] => 12/578752
[patent_app_country] => US
[patent_app_date] => 2009-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3760
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20100099844.pdf
[firstpage_image] =>[orig_patent_app_number] => 12578752
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/578752 | Hydrophobin solution containing antifoam | Oct 13, 2009 | Issued |
Array
(
[id] => 6493177
[patent_doc_number] => 20100209406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'BACILLUS STRAINS AND METHODS FOR REDUCING E. COLI DISEASE AND ENHANCING PERFORMANCE'
[patent_app_type] => utility
[patent_app_number] => 12/573390
[patent_app_country] => US
[patent_app_date] => 2009-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 17600
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20100209406.pdf
[firstpage_image] =>[orig_patent_app_number] => 12573390
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/573390 | BACILLUS STRAINS AND METHODS FOR REDUCING E. COLI DISEASE AND ENHANCING PERFORMANCE | Oct 4, 2009 | Abandoned |
Array
(
[id] => 6165756
[patent_doc_number] => 20110195483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-11
[patent_title] => 'Non-Natural Amino Acid Replication-Dependent Microorganisms and Vaccines'
[patent_app_type] => utility
[patent_app_number] => 13/120255
[patent_app_country] => US
[patent_app_date] => 2009-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 51290
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0195/20110195483.pdf
[firstpage_image] =>[orig_patent_app_number] => 13120255
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/120255 | Non-natural amino acid replication-dependent microorganisms and vaccines | Sep 27, 2009 | Issued |
Array
(
[id] => 7650902
[patent_doc_number] => 20110300171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'FACTOR H BINDING PROTEIN IMMUNOGENS'
[patent_app_type] => utility
[patent_app_number] => 13/063458
[patent_app_country] => US
[patent_app_date] => 2009-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 20097
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0300/20110300171.pdf
[firstpage_image] =>[orig_patent_app_number] => 13063458
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/063458 | FACTOR H BINDING PROTEIN IMMUNOGENS | Sep 13, 2009 | Abandoned |